195 related articles for article (PubMed ID: 15696553)
21. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients.
Wieczorek S; Hoffjan S; Chan A; Rey L; Harper L; Fricke H; Holle JU; Gross WL; Epplen JT; Lamprecht P
Genes Immun; 2009 Sep; 10(6):591-5. PubMed ID: 19536154
[TBL] [Abstract][Full Text] [Related]
22. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective.
Harrold LR; Andrade SE; Go AS; Buist AS; Eisner M; Vollmer WM; Chan KA; Frazier EA; Weller PF; Wechsler ME; Yood RA; Davis KJ; Platt R
J Rheumatol; 2005 Jun; 32(6):1076-80. PubMed ID: 15940771
[TBL] [Abstract][Full Text] [Related]
23. Are environmental factors important in primary systemic vasculitis? A case-control study.
Lane SE; Watts RA; Bentham G; Innes NJ; Scott DG
Arthritis Rheum; 2003 Mar; 48(3):814-23. PubMed ID: 12632437
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement.
Gibelin A; Maldini C; Mahr A
Semin Respir Crit Care Med; 2011 Jun; 32(3):264-73. PubMed ID: 21674413
[TBL] [Abstract][Full Text] [Related]
25. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany.
Reinhold-Keller E; Zeidler A; Gutfleisch J; Peter HH; Raspe HH; Gross WL
Rheumatology (Oxford); 2000 Dec; 39(12):1396-402. PubMed ID: 11136884
[TBL] [Abstract][Full Text] [Related]
26. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe.
Watts RA; Gonzalez-Gay MA; Lane SE; Garcia-Porrua C; Bentham G; Scott DG
Ann Rheum Dis; 2001 Feb; 60(2):170-2. PubMed ID: 11156552
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
28. Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis.
Hattori N; Mori K; Misu K; Koike H; Ichimura M; Sobue G
J Rheumatol; 2002 Jul; 29(7):1408-14. PubMed ID: 12136898
[TBL] [Abstract][Full Text] [Related]
29. Improved differentiation between Churg-Strauss syndrome and Wegener's granulomatosis by an artificial neural network.
Schmitt WH; Linder R; Reinhold-Keller E; Gross WL
Arthritis Rheum; 2001 Aug; 44(8):1887-96. PubMed ID: 11508442
[TBL] [Abstract][Full Text] [Related]
30. Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001.
Knight A; Ekbom A; Brandt L; Askling J
J Rheumatol; 2006 Oct; 33(10):2060-3. PubMed ID: 16960922
[TBL] [Abstract][Full Text] [Related]
31. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a new algorithm in classification of systemic vasculitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Rheumatology (Oxford); 2008 May; 47(5):708-12. PubMed ID: 18390585
[TBL] [Abstract][Full Text] [Related]
33. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
[TBL] [Abstract][Full Text] [Related]
34. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.
Tidman M; Olander R; Svalander C; Danielsson D
J Intern Med; 1998 Aug; 244(2):133-41. PubMed ID: 10095799
[TBL] [Abstract][Full Text] [Related]
35. Primary systemic vasculitis with severe α1-antitrypsin deficiency revisited.
Mohammad A; Segelmark M
Scand J Rheumatol; 2014; 43(3):242-5. PubMed ID: 24313382
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden.
Mossberg M; Segelmark M; Kahn R; Englund M; Mohammad AJ
Scand J Rheumatol; 2018 Jul; 47(4):295-302. PubMed ID: 29409373
[TBL] [Abstract][Full Text] [Related]
37. ANCA vasculitis in the elderly.
Hoganson DD; From AM; Michet CJ
J Clin Rheumatol; 2008 Apr; 14(2):78-81. PubMed ID: 18391675
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.
Watts RA; Lane SE; Bentham G; Scott DG
Arthritis Rheum; 2000 Feb; 43(2):414-9. PubMed ID: 10693883
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
40. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
